Skip to main content
HairCited

Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?

Shreya Singh, Anant Patil, Nika Kianfar, Anna Waśkiel-Burnat, Lidia Rudnicka et al.
Review Clinical and experimental dermatology 2022 9 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D35881665'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Abstract

Minoxidil solution is used for the treatment of androgenetic alopecia (AGA). Minoxidil 5% solution has been shown to have superior efficacy to minoxidil 2% solution, it is unknown whether concentrations of minoxidil > 5% provide additional clinical benefit. We performed a review of the literature to examine the evidence on the efficacy and safety of higher concentrations of minoxidil in AGA. A search of the PubMed database was performed using the keywords 'minoxidil', 'androgenic alopecia' and 'pattern hair loss'. Relevant articles, including clinical trials, other clinical studies, case series and case reports published in English were considered for review. In addition, relevant references from the bibliography section of the retrieved articles were also reviewed.

Zusammenfassung

A review of the literature was performed to examine the evidence on the efficacy and safety of higher concentrations of minoxidil in AGA and found no evidence of additional clinical benefit.

Used In Evidence Reviews

Similar Papers